Skip to Content

COPAXONE 40 MG/ML SOLUTION FOR INJECTION PRE-FILLED SYRINGE

Active substance(s): GLATIRAMER ACETATE / GLATIRAMER ACETATE / GLATIRAMER ACETATE

View full screen / Print PDF » Download PDF ⇩
Transcript
Copaxone 40 mg / UK Side A
(Kfar Saba + Runcorn)
280x380 mm Folded: 140x65 mm

xxxKxxxxxxxxx
PExxxx

Wash your hands thoroughly with soap and water.
If you wish to use the Copaxone injection device to make your injection, please refer
to the instructions for use provided together with the Copaxone injection device.
Choose the injection site, using the diagrams in Figure 1.
There are seven possible areas on your body for injection: arms, thighs, hips and
stomach (belly). Within each injection area there are several injection sites. Choose a
different site for each injection. This will reduce the likeliness of any irritation or pain
at the site of the injection. Rotate the injection sites within an area. Do not use the
same site each time.

Package leaflet: Information for the user
®

40 mg/ml
solution for injection, pre-filled syringe
glatiramer acetate
Read all of this leaflet carefully before you start using this medicine because it
contains important information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may
harm them, even if their signs of illness are the same as yours.
• If you get any of the side effects, talk to your doctor or pharmacist. This includes any
possible side effects not listed in this leaflet. See section 4.

Please note: do not inject in any area that is painful or discoloured or where you feel
firm knots or lumps.
You should consider having a planned schedule for rotating injection sites and
making a note of it in a diary. There are some sites on your body that may be difficult
for self-injection (like the back of your arm). If you want to use these, you may require
assistance.

What is in this leaflet:
1. What Copaxone 40 mg/ml is and what it is used for
2. What you need to know before you use Copaxone 40 mg/ml
3. How to use Copaxone 40 mg/ml
4. Possible side effects
5. How to store Copaxone 40 mg/ml
6. Contents of the pack and other information

1. What Copaxone 40 mg/ml is and what it is used for
Copaxone 40 mg/ml is a medicinal product, administered three times a week, which
modifies the way in which your body’s immune system works (it is classed as an
immunomodulating agent). The symptoms of multiple sclerosis (MS) are thought to
be caused by a defect in the body’s immune system. This produces patches of
inflammation in the brain and spinal cord.
Copaxone 40 mg/ml is used to reduce the number of times you suffer attacks of MS
(relapses). It has not been demonstrated to help if you have any form of MS which
does not have relapses, or hardly any relapses. Copaxone 40 mg/ml may not have
any effect on the length of time an MS attack lasts, or how badly you suffer during an
attack.

2. What you need to know before you use Copaxone 40 mg/ml
Do not use Copaxone 40 mg/ml
• if you are allergic to glatiramer acetate or any of the other ingredients of this
medicine (listed in section 6).
Warnings and precautions
Talk to your doctor or pharmacist before using Copaxone 40 mg/ml
• if you have any kidney or heart problems as you may need to have regular tests and
check-ups.
Children
Copaxone is not to be used in children below the age of 18 years.
Elderly
Copaxone has not been specifically studied in the elderly. Please ask your doctor for
advice.
Other medicines and Copaxone 40 mg/ml
Tell your doctor or pharmacist if you are taking, have recently taken or might take any
other medicines.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to
have a baby, ask your doctor for advice and consideration regarding Copaxone
treatment during pregnancy and/or lactation.

How to inject:
• Remove the syringe from its protective blister by peeling back the blister lid.
• Remove the shield from the needle.
• Gently pinch up the skin with the thumb and forefinger of the free hand (Figure 2).
• Push the needle into the skin as shown in Figure 3.
• Inject the medicine by steadily pushing the plunger all the way down until the
syringe is empty.
• Pull the syringe and needle straight out.
• Discard the syringe in a safe disposal container. Do not put used syringes into the
household waste but dispose of them carefully in a puncture-proof container as
recommended by your doctor or nurse.

Driving and using machines
Copaxone 40 mg/ml is not known to influence the ability to drive or operate
machinery.

3. How to use Copaxone 40 mg/ml
Always use this medicine exactly as your doctor has told you. Check with your doctor
or pharmacist if you are not sure.

If you have the impression that the effect of Copaxone 40 mg/ml is too strong or too
weak, talk to your doctor.

The dose in adults is one pre-filled syringe (40 mg of glatiramer acetate),
administered under the skin (subcutaneously) three times a week, injected at least
48 hours apart, for example Monday Wednesday and Friday. It is recommended to
administer the drug on the same days every week.

If you use more Copaxone 40 mg/ml than you should
Talk to your doctor immediately.

It is very important to inject Copaxone 40 mg/ml properly:
• Into the tissue under the skin (subcutaneous tissue) only (see “Instructions for Use”
below).
• At the dose instructed by your doctor. Use only the dose prescribed by your doctor.
• Never use the same syringe more than once. Any unused product or waste must be
discarded.
• Do not mix or co-administer the content of Copaxone 40 mg/ml pre-filled syringes
with any product.
• If the solution contains particles, do not use it. Use a new syringe.
The first time you use Copaxone 40 mg/ml you will be given full instructions and will
be supervised by a doctor or nurse. They will be with you while you give yourself the
injection and for half an hour afterwards, just to make sure you do not have any
problems.
Instructions for Use
Read these instructions carefully before using Copaxone 40 mg/ml.
Before the injection, make sure you have everything you need:
• One blister with one Copaxone 40 mg/ml pre-filled syringe
• Disposal unit for used needles and syringes.
• For each injection, take only one blister with one pre-filled syringe from the
package. Keep all remaining syringes in the box.
• If your syringe has been stored in the refrigerator, take the blister containing the
syringe out at least 20 minutes before you will inject the medicine so that it warms
up to room temperature.

Teva Pharmaceuticals Europe B.V
Effective Date: TBD

If you forget to use Copaxone 40 mg/ml
Use it as soon as you remember or are able to use it, then skip the following day. Do
not use a double dose to make up for forgotten individual doses. If possible you
should return to your regular administration schedule the following week.
If you stop using Copaxone 40 mg/ml
Do not stop using Copaxone 40 mg/ml without consulting your doctor.
If you have any further questions on the use of this medicine, ask your doctor or
pharmacist.

4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets
them.
Allergic Reactions (hypersensitivity)
You may develop a serious allergic reaction to this medicine but it is uncommon.
Stop using Copaxone 40 mg/ml and contact your doctor immediately or go to
the nearest hospital casualty department, if you notice any sign of these side
effects:
• rash (red spots or nettle rash)
• swelling of the eyelids, face or lips
• sudden shortness of breath
• convulsions (fits)
• fainting

REG0152576
Valid For 7 Days from 21-Apr-2017

Version 2.2

Approved
Page 2 of 4

Copaxone 40 mg / UK Side B
(Kfar Saba + Runcorn)
280x380 mm Folded: 140x65 mm

Other reactions following injection (immediate post-injection reaction)
Some people may get one or more of the following symptoms within minutes after
injecting Copaxone 40 mg/ml. They normally do not cause any problems and usually
disappear within half an hour.
However, if the following symptoms last longer than 30 minutes, tell your doctor
immediately or go to the casualty department at your nearest hospital:
• flushing (reddening) of the chest or face (vasodilatation)
• shortness of breath
• chest pain
• pounding and rapid heartbeat (palpitations, tachycardia)

5. How to store Copaxone 40 mg/ml

In general the side effects reported by patients using Copaxone 40 mg/ml three
times a week were also reported in patients who used Copaxone 20 mg/ml (see
the following list).

Keep the pre-filled syringes in the outer carton in order to protect from light.

Very common (may affect more than 1 in 10 people)
• infection, flu
• anxiety, depression
• headache
• feeling sick
• skin rash
• pain in the joints or back
• feeling weak, skin reactions at the injection site including reddening of skin, pain,
formation of wheals, itching, tissue swelling, inflammation and hypersensitivity
(these injection site reactions are not unusual and normally decrease over time),
non-specific pain

Keep this medicine out of the sight and reach of children.
Store in a refrigerator (2°C – 8°C).
Copaxone 40 mg/ml pre-filled syringes can be kept for up to one month outside the
refrigerator between 15°C and 25°C. You can do this only once. After one month any
Copaxone 40 mg/ml pre-filled syringes that have not been used and are still in their
original packaging must be returned to the refrigerator.
Do not freeze.

Do not use this medicine after the expiry date which is stated on the label and carton
(EXP). The expiry date refers to the last day of that month.
Dispose of any syringes that contain particles.
Do not throw away any medicine via wastewater or household waste. Ask your
pharmacist how to throw away medicines you no longer use. These measures will
help protect the environment.

6. Contents of the pack and other information
What Copaxone 40 mg/ml contains
• The active substance is glatiramer acetate. 1 ml solution for injection (the contents
of one pre-filled syringe) contains 40 mg glatiramer acetate.
• The other ingredients are mannitol and water for injections.

Common (may affect up to 1 in 10 people)
• inflammation of the respiratory tract, gastric flu, cold sore, inflammation of the ears,
runny nose, tooth abscess, vaginal thrush
• non-malignant skin growth (non-malignant neoplasm of skin), tissue growth
(neoplasm)
• lymph node swelling
• allergic reactions
• loss of appetite, weight gain
• nervousness
• altered taste, increased tightness of muscle tone, migraine, speech disorder,
fainting, tremor
• double vision, eye disorder
• ear disorder
• cough, hay fever
• disorder of anus or rectum, constipation, tooth decay, indigestion, difficulty in
swallowing, bowel incontinence, vomiting
• abnormal liver function test
• bruising, excessive sweating, itching, skin disorder, nettle rash
• neck pain
• urge to empty your bladder, frequent urination, inability to empty your bladder
appropriately
• chill, face swelling, wasting of tissue under the skin at injection site, local reaction,
peripheral swelling due to build-up of fluid, fever

What Copaxone 40 mg/ml looks like and contents of the pack
Copaxone 40 mg/ml solution for injection in pre-filled syringe is a sterile, clear
solution, free of visible particles. If the solution contains particles, throw it away and
start again. Use a new syringe.

Uncommon (may affect up to 1 in 100 people)
• abscess, inflammation of skin and the soft tissue underneath, boils, shingles,
inflammation of kidney
• skin cancer
• increased white blood cell count, reduced white blood cell count, spleen
enlargement, low blood platelet count, change in form of white blood cells
• enlarged thyroid, overactive thyroid
• low alcohol tolerance, gout, increase in blood fat levels, increase in blood sodium,
decrease in serum ferritin
• abnormal dreams, confusion, euphoric mood, seeing, hearing, smelling, tasting or
feeling something that is not there (hallucinations), aggression, abnormal elevated
mood, personality disorder, suicide attempt
• hand numbness and pain (carpal tunnel syndrome), mental disorder, fits
(convulsion), problems with handwriting and reading, muscle disorders, problems
with movement, muscle spasm, nerve inflammation, abnormal nerve-muscle link
leading to abnormal muscle function, involuntary rapid movement of the eyeballs,
paralysis, foot drop (peroneal nerve palsy), unconscious state (stupor), visual blind
spots
• cataract, eye lesion in the cornea, dry eye, eye bleeding, droopy upper eyelid, pupil
widening, wasting of the optic nerve leading to visual problems
• extra heart beats, slow heart beats, episodic fast heart beats
• varicose vein
• periodic stops in breathing, nose bleeding, abnormally fast or deep breathing
(hyperventilation), tight feeling in the throat, lung disorder, inability to breath due to
throat tightness (choking sensation)
• bowel inflammation, polyps in the colon, intestine inflammation, burping, ulcer in the
gullet, inflammation of the gums, rectal bleeding, enlarged salivary glands
• gallstones, liver enlargement
• swelling of the skin and soft tissues, skin contact rash, painful red skin lumps, skin
lumps
• swelling, inflammation and pain of joints (arthritis or osteoarthritis), inflammation
and pain of fluid-sacs lining the joint (exist in some of the joints), flank pain,
decrease in the mass of muscles
• blood in the urine, kidney stones, urinary tract disorder, urine abnormality
• abortion
• breast swelling, difficulties getting an erection, fall down or slip out of the place of
pelvic organs (pelvic prolapse), sustained erections, disorders of prostate,
abnormal PAP smear test (Smear Cervix Abnormal), testes disorder, vaginal
bleeding, vaginal disorder
• cyst, hangover, low body temperature (hypothermia), non-specific inflammation,
destruction of tissue at the injection site, problems with mucous membranes
• disorders after vaccination

This medicinal product is authorised in the Member States of the EEA under
the name COPAXONE 40 mg/ml in:
Austria, Belgium, Croatia, Czech Republic, Cyprus, Denmark, Estonia, Finland,
Germany, Greece, Hungary, Ireland, Iceland, Italy, Latvia, Lithuania, Luxembourg,
Malta, Norway, Poland, Portugal, Spain, Sweden, Slovakia, Slovenia, The
Netherlands, United Kingdom

Copaxone 40 mg/ml is available in packs containing 3 or 12 pre-filled syringes of 1
ml solution for injection or in a multipack comprising 3 cartons, each containing 12
pre-filled syringes of 1 ml of solution for injection.
Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder:
Teva Pharmaceuticals Ltd.
Ridings Point, Whistler Drive
Castleford, West Yorkshire
WF10 5HX
UK
Manufacturer:
Teva Pharmaceuticals Europe B.V.
Swensweg 5
2031 GA Haarlem
The Netherlands

This leaflet was last revised in 03/2017
PL 10921/0026

Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any
possible side effects not listed in this leaflet. You can also report side effects directly
via the national reporting system listed in Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any
possible side effects not listed in this leaflet. You can also report side effects directly
via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of this
medicine.

30240-B

Teva Pharmaceuticals Europe B.V
Effective Date: TBD

REG0152576
Valid For 7 Days from 21-Apr-2017

Version 2.2

Approved
Page 3 of 4

Wash your hands thoroughly with soap and water.
If you wish to use the Copaxone injection device to make your injection, please refer
to the instructions for use provided together with the Copaxone injection device.
Choose the injection site, using the diagrams in Figure 1.
There are seven possible areas on your body for injection: arms, thighs, hips and
stomach (belly). Within each injection area there are several injection sites. Choose a
different site for each injection. This will reduce the likeliness of any irritation or pain
at the site of the injection. Rotate the injection sites within an area. Do not use the
same site each time.

Package leaflet: Information for the user
®

40 mg/ml
solution for injection, pre-filled syringe
glatiramer acetate
Read all of this leaflet carefully before you start using this medicine because it
contains important information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may
harm them, even if their signs of illness are the same as yours.
• If you get any of the side effects, talk to your doctor or pharmacist. This includes any
possible side effects not listed in this leaflet. See section 4.

Please note: do not inject in any area that is painful or discoloured or where you feel
firm knots or lumps.
You should consider having a planned schedule for rotating injection sites and
making a note of it in a diary. There are some sites on your body that may be difficult
for self-injection (like the back of your arm). If you want to use these, you may require
assistance.

What is in this leaflet:
1. What Copaxone 40 mg/ml is and what it is used for
2. What you need to know before you use Copaxone 40 mg/ml
3. How to use Copaxone 40 mg/ml
4. Possible side effects
5. How to store Copaxone 40 mg/ml
6. Contents of the pack and other information

1. What Copaxone 40 mg/ml is and what it is used for
Copaxone 40 mg/ml is a medicinal product, administered three times a week, which
modifies the way in which your body’s immune system works (it is classed as an
immunomodulating agent). The symptoms of multiple sclerosis (MS) are thought to
be caused by a defect in the body’s immune system. This produces patches of
inflammation in the brain and spinal cord.
Copaxone 40 mg/ml is used to reduce the number of times you suffer attacks of MS
(relapses). It has not been demonstrated to help if you have any form of MS which
does not have relapses, or hardly any relapses. Copaxone 40 mg/ml may not have
any effect on the length of time an MS attack lasts, or how badly you suffer during an
attack.

2. What you need to know before you use Copaxone 40 mg/ml
Do not use Copaxone 40 mg/ml
• if you are allergic to glatiramer acetate or any of the other ingredients of this
medicine (listed in section 6).
Warnings and precautions
Talk to your doctor or pharmacist before using Copaxone 40 mg/ml
• if you have any kidney or heart problems as you may need to have regular tests and
check-ups.
Children
Copaxone is not to be used in children below the age of 18 years.
Elderly
Copaxone has not been specifically studied in the elderly. Please ask your doctor for
advice.
Other medicines and Copaxone 40 mg/ml
Tell your doctor or pharmacist if you are taking, have recently taken or might take any
other medicines.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to
have a baby, ask your doctor for advice and consideration regarding Copaxone
treatment during pregnancy and/or lactation.

How to inject:
• Remove the syringe from its protective blister by peeling back the blister lid.
• Remove the shield from the needle.
• Gently pinch up the skin with the thumb and forefinger of the free hand (Figure 2).
• Push the needle into the skin as shown in Figure 3.
• Inject the medicine by steadily pushing the plunger all the way down until the
syringe is empty.
• Pull the syringe and needle straight out.
• Discard the syringe in a safe disposal container. Do not put used syringes into the
household waste but dispose of them carefully in a puncture-proof container as
recommended by your doctor or nurse.

Driving and using machines
Copaxone 40 mg/ml is not known to influence the ability to drive or operate
machinery.

3. How to use Copaxone 40 mg/ml
Always use this medicine exactly as your doctor has told you. Check with your doctor
or pharmacist if you are not sure.

If you have the impression that the effect of Copaxone 40 mg/ml is too strong or too
weak, talk to your doctor.

The dose in adults is one pre-filled syringe (40 mg of glatiramer acetate),
administered under the skin (subcutaneously) three times a week, injected at least
48 hours apart, for example Monday Wednesday and Friday. It is recommended to
administer the drug on the same days every week.

If you use more Copaxone 40 mg/ml than you should
Talk to your doctor immediately.

It is very important to inject Copaxone 40 mg/ml properly:
• Into the tissue under the skin (subcutaneous tissue) only (see “Instructions for Use”
below).
• At the dose instructed by your doctor. Use only the dose prescribed by your doctor.
• Never use the same syringe more than once. Any unused product or waste must be
discarded.
• Do not mix or co-administer the content of Copaxone 40 mg/ml pre-filled syringes
with any product.
• If the solution contains particles, do not use it. Use a new syringe.
The first time you use Copaxone 40 mg/ml you will be given full instructions and will
be supervised by a doctor or nurse. They will be with you while you give yourself the
injection and for half an hour afterwards, just to make sure you do not have any
problems.
Instructions for Use
Read these instructions carefully before using Copaxone 40 mg/ml.
Before the injection, make sure you have everything you need:
• One blister with one Copaxone 40 mg/ml pre-filled syringe
• Disposal unit for used needles and syringes.
• For each injection, take only one blister with one pre-filled syringe from the
package. Keep all remaining syringes in the box.
• If your syringe has been stored in the refrigerator, take the blister containing the
syringe out at least 20 minutes before you will inject the medicine so that it warms
up to room temperature.

Teva Pharmaceuticals Europe B.V
Effective Date: TBD

If you forget to use Copaxone 40 mg/ml
Use it as soon as you remember or are able to use it, then skip the following day. Do
not use a double dose to make up for forgotten individual doses. If possible you
should return to your regular administration schedule the following week.
If you stop using Copaxone 40 mg/ml
Do not stop using Copaxone 40 mg/ml without consulting your doctor.
If you have any further questions on the use of this medicine, ask your doctor or
pharmacist.

4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets
them.
Allergic Reactions (hypersensitivity)
You may develop a serious allergic reaction to this medicine but it is uncommon.
Stop using Copaxone 40 mg/ml and contact your doctor immediately or go to
the nearest hospital casualty department, if you notice any sign of these side
effects:
• rash (red spots or nettle rash)
• swelling of the eyelids, face or lips
• sudden shortness of breath
• convulsions (fits)
• fainting

REG0208957
Valid For 7 Days from 21-Apr-2017

Version 1.2

Approved
Page 2 of 4

Other reactions following injection (immediate post-injection reaction)
Some people may get one or more of the following symptoms within minutes after
injecting Copaxone 40 mg/ml. They normally do not cause any problems and usually
disappear within half an hour.
However, if the following symptoms last longer than 30 minutes, tell your doctor
immediately or go to the casualty department at your nearest hospital:
• flushing (reddening) of the chest or face (vasodilatation)
• shortness of breath
• chest pain
• pounding and rapid heartbeat (palpitations, tachycardia)

5. How to store Copaxone 40 mg/ml

In general the side effects reported by patients using Copaxone 40 mg/ml three
times a week were also reported in patients who used Copaxone 20 mg/ml (see
the following list).

Keep the pre-filled syringes in the outer carton in order to protect from light.

Very common (may affect more than 1 in 10 people)
• infection, flu
• anxiety, depression
• headache
• feeling sick
• skin rash
• pain in the joints or back
• feeling weak, skin reactions at the injection site including reddening of skin, pain,
formation of wheals, itching, tissue swelling, inflammation and hypersensitivity
(these injection site reactions are not unusual and normally decrease over time),
non-specific pain

Keep this medicine out of the sight and reach of children.
Store in a refrigerator (2°C – 8°C).
Copaxone 40 mg/ml pre-filled syringes can be kept for up to one month outside the
refrigerator between 15°C and 25°C. You can do this only once. After one month any
Copaxone 40 mg/ml pre-filled syringes that have not been used and are still in their
original packaging must be returned to the refrigerator.
Do not freeze.

Do not use this medicine after the expiry date which is stated on the label and carton
(EXP). The expiry date refers to the last day of that month.
Dispose of any syringes that contain particles.
Do not throw away any medicine via wastewater or household waste. Ask your
pharmacist how to throw away medicines you no longer use. These measures will
help protect the environment.

6. Contents of the pack and other information
What Copaxone 40 mg/ml contains
• The active substance is glatiramer acetate. 1 ml solution for injection (the contents
of one pre-filled syringe) contains 40 mg glatiramer acetate.
• The other ingredients are mannitol and water for injections.

Common (may affect up to 1 in 10 people)
• inflammation of the respiratory tract, gastric flu, cold sore, inflammation of the ears,
runny nose, tooth abscess, vaginal thrush
• non-malignant skin growth (non-malignant neoplasm of skin), tissue growth
(neoplasm)
• lymph node swelling
• allergic reactions
• loss of appetite, weight gain
• nervousness
• altered taste, increased tightness of muscle tone, migraine, speech disorder,
fainting, tremor
• double vision, eye disorder
• ear disorder
• cough, hay fever
• disorder of anus or rectum, constipation, tooth decay, indigestion, difficulty in
swallowing, bowel incontinence, vomiting
• abnormal liver function test
• bruising, excessive sweating, itching, skin disorder, nettle rash
• neck pain
• urge to empty your bladder, frequent urination, inability to empty your bladder
appropriately
• chill, face swelling, wasting of tissue under the skin at injection site, local reaction,
peripheral swelling due to build-up of fluid, fever

What Copaxone 40 mg/ml looks like and contents of the pack
Copaxone 40 mg/ml solution for injection in pre-filled syringe is a sterile, clear
solution, free of visible particles. If the solution contains particles, throw it away and
start again. Use a new syringe.

Uncommon (may affect up to 1 in 100 people)
• abscess, inflammation of skin and the soft tissue underneath, boils, shingles,
inflammation of kidney
• skin cancer
• increased white blood cell count, reduced white blood cell count, spleen
enlargement, low blood platelet count, change in form of white blood cells
• enlarged thyroid, overactive thyroid
• low alcohol tolerance, gout, increase in blood fat levels, increase in blood sodium,
decrease in serum ferritin
• abnormal dreams, confusion, euphoric mood, seeing, hearing, smelling, tasting or
feeling something that is not there (hallucinations), aggression, abnormal elevated
mood, personality disorder, suicide attempt
• hand numbness and pain (carpal tunnel syndrome), mental disorder, fits
(convulsion), problems with handwriting and reading, muscle disorders, problems
with movement, muscle spasm, nerve inflammation, abnormal nerve-muscle link
leading to abnormal muscle function, involuntary rapid movement of the eyeballs,
paralysis, foot drop (peroneal nerve palsy), unconscious state (stupor), visual blind
spots
• cataract, eye lesion in the cornea, dry eye, eye bleeding, droopy upper eyelid, pupil
widening, wasting of the optic nerve leading to visual problems
• extra heart beats, slow heart beats, episodic fast heart beats
• varicose vein
• periodic stops in breathing, nose bleeding, abnormally fast or deep breathing
(hyperventilation), tight feeling in the throat, lung disorder, inability to breath due to
throat tightness (choking sensation)
• bowel inflammation, polyps in the colon, intestine inflammation, burping, ulcer in the
gullet, inflammation of the gums, rectal bleeding, enlarged salivary glands
• gallstones, liver enlargement
• swelling of the skin and soft tissues, skin contact rash, painful red skin lumps, skin
lumps
• swelling, inflammation and pain of joints (arthritis or osteoarthritis), inflammation
and pain of fluid-sacs lining the joint (exist in some of the joints), flank pain,
decrease in the mass of muscles
• blood in the urine, kidney stones, urinary tract disorder, urine abnormality
• abortion
• breast swelling, difficulties getting an erection, fall down or slip out of the place of
pelvic organs (pelvic prolapse), sustained erections, disorders of prostate,
abnormal PAP smear test (Smear Cervix Abnormal), testes disorder, vaginal
bleeding, vaginal disorder
• cyst, hangover, low body temperature (hypothermia), non-specific inflammation,
destruction of tissue at the injection site, problems with mucous membranes
• disorders after vaccination

This medicinal product is authorised in the Member States of the EEA under
the name COPAXONE 40 mg/ml in:
Austria, Belgium, Croatia, Czech Republic, Cyprus, Denmark, Estonia, Finland,
Germany, Greece, Hungary, Ireland, Iceland, Italy, Latvia, Lithuania, Luxembourg,
Malta, Norway, Poland, Portugal, Spain, Sweden, Slovakia, Slovenia, The
Netherlands, United Kingdom

Copaxone 40 mg/ml is available in packs containing 3 or 12 pre-filled syringes of 1
ml solution for injection or in a multipack comprising 3 cartons, each containing 12
pre-filled syringes of 1 ml of solution for injection.
Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder:
Teva Pharmaceuticals Ltd.
Ridings Point, Whistler Drive
Castleford, West Yorkshire
WF10 5HX
UK
Manufacturer:
Norton Healthcare Limited T/A IVAX Pharmaceuticals UK (Teva Runcorn)
Aston Lane North, Whitehouse Vale Industrial Estate
Runcorn, Cheshire, WA7 3FA
United Kingdom

This leaflet was last revised in 03/2017
PL 10921/0026

Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any
possible side effects not listed in this leaflet. You can also report side effects directly
via the national reporting system listed in Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any
possible side effects not listed in this leaflet. You can also report side effects directly
via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of this
medicine.

32616-B

Teva Pharmaceuticals Europe B.V
Effective Date: TBD

REG0208957
Valid For 7 Days from 21-Apr-2017

Version 1.2

Approved
Page 3 of 4

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide